Axogen, Inc. — Director's Dealing 2015

Jan 6, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2013-01-02

Reporting Person: Grooms Jamie Mark (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-01-02	Stock Option (right to purchase)	$2.75	A	13000	Acquired	2019-12-31	Common Stock (13000)	Direct
2014-01-02	Stock Option (right to purchase)	$4.81	A	15000	Acquired	2020-12-31	Common Stock (15000)	Direct
2015-01-02	Stock Option (right to purchase)	$3.60	A	15000	Acquired	2022-01-02	Common Stock (15000)	Direct

Footnotes

F1: Options granted as compensation for service on the board of directors. All options vested on the date of grant.

F2: Annual option grant as compensation for services on the board of directors. Options vest as to 25% of total share amount at the end of each fiscal quarter, becoming fully vested after one year.